Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CLRB | Cellectar Biosciences, Inc. | Chief Financial Officer | Jan 25, 2022 | |||
FEMY | FEMASYS INC | Chief Financial Officer | Feb 1, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|